NantWorks, the company of Patrick Soon-Shiong, has acquired a majority stake in Integrity Healthcare, Verity Health System's management company. Through the deal, NantWorks will become the operator of six California hospitals, including St. Vincent Medical Center.
After his recent appointment to a national health IT advisory committee, Soon-Shiong explained how his life's work is now converging towards major advances in cancer and healthcare more broadly.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
NantWorks' Patrick Soon-Shiong and leaders from Norton Healthcare and Sutter Health have been appointed to a new Health IT Advisory Committee formed through the passing of the 21st Century Cures Act.
After 15 years of research, Patrick Soon-Shiong has unveiled the Nant Cancer Vaccine, bringing together myriad biology and technology advances made throughout his NantWorks empire.
Also, GSK chief bemoans lack of price transparency in the U.S., feds investigate pharma-PBM contracts and Memorial Hermann gets its first physician CEO.
Another load of cash - and little further insight - is on the books for Patrick Soon-Shiong cancer immunotherapy startup NantCell.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The National Immunotherapy Coalition will work towards a new cancer initiative called "Cancer MoonShot 2020" that will take important steps in eradicating cancer.
The desire to include payers on the NantHealth platform apparently has long been part of Soon-Shiong's plan.
Dr. Patrick Soon-Shiong confirmed the plan in an interview with the Los Angeles Times. His NantKwest immuno-oncology company has lost half its value since a July IPO.
Precision Biologics, a Maryland developer of cancer immunotherapies and companion diagnostics, just received a $50 million investment from billionaire Patrick Soon-Shiong's mega-startup, NantWorks.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Dr. Patrick Soon-Shiong has two more fundraises under his companies' belt: According to an SEC filing, immuno-oncology startup NantCell has raised $100 million and precision medicine startup NantOmics has raised $150 million.
In a joint press release, NantHealth and Allscripts said that they would jointly integrate their software via application provider interfaces
Isn't Theranos supposed to be a smart company? The MIT Technology Review highlights each year what it considers the world's "smartest companies." Understandably, several have been left out.
The mysterious company just allocated $75 million to its NantCell division - putting some serious funding behind its precision medicine and cancer immunotherapy efforts.
Billionaire investor Patrick Soon-Shiong buys the rights to a next-gen Abraxane from Sorrento Therapeutics - building on the drug that launched his own fortune.